XWELL, Inc. (XWEL)
NASDAQ: XWEL · IEX Real-Time Price · USD
1.740
-0.050 (-2.79%)
May 17, 2024, 4:00 PM EDT - Market closed
XWELL Revenue
XWELL had revenue of $31.77M in the twelve months ending March 31, 2024, down -18.44% year-over-year. Revenue in the quarter ending March 31, 2024 was $8.73M with 23.55% year-over-year growth. In the year 2023, XWELL had annual revenue of $30.11M, a decrease of -46.18%.
Revenue (ttm)
$31.77M
Revenue Growth
-18.44%
P/S Ratio
0.24
Revenue / Employee
$119,444
Employees
266
Market Cap
7.53M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.11M | -25.83M | -46.18% |
Dec 31, 2022 | 55.94M | -17.79M | -24.13% |
Dec 31, 2021 | 73.73M | 65.34M | 779.30% |
Dec 31, 2020 | 8.39M | -40.13M | -82.72% |
Dec 31, 2019 | 48.52M | -1.58M | -3.15% |
Dec 31, 2018 | 50.09M | 1.27M | 2.60% |
Dec 31, 2017 | 48.82M | 36.84M | 307.33% |
Dec 31, 2016 | 11.99M | -10.70M | -47.17% |
Dec 31, 2015 | 22.69M | 21.26M | 1,492.07% |
Dec 31, 2014 | 1.43M | 325.00K | 29.55% |
Dec 31, 2013 | 1.10M | 1.00M | 1,000.00% |
Dec 31, 2012 | 100.00K | -618.00K | -86.07% |
Dec 31, 2011 | 718.00K | 507.00K | 240.28% |
Dec 31, 2010 | 211.00K | 191.00K | 955.00% |
Dec 31, 2009 | 20.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Telesis Bio | 24.63M |
Intelligent Bio Solutions | 3.21M |
Trevena | 3.14M |
TFF Pharmaceuticals | 885.72K |
Vaccinex | 124.00K |
Oragenics | 20.63K |
Heart Test Laboratories | 18.60K |
XWEL News
- 2 days ago - XWELL, Inc. Reports First Quarter 2024 Results - GlobeNewsWire
- 16 days ago - XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport - GlobeNewsWire
- 4 weeks ago - XWELL, Inc. Reports Fiscal Year 2023 Results - GlobeNewsWire
- 4 weeks ago - XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024 - GlobeNewsWire
- 6 weeks ago - XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K - GlobeNewsWire
- 2 months ago - CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago - PRNewsWire
- 5 months ago - XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors - GlobeNewsWire
- 6 months ago - XWELL Opens New XpresSpa Location in Abu Dhabi International Airport - GlobeNewsWire